Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.
about
Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersDiagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancerEvaluating the performance of PI-RADS v2 in the non-academic setting.Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.PI-RADS version 2: quantitative analysis aids reliable interpretation of diffusion-weighted imaging for prostate cancer.Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population.Characterizing indeterminate (Likert-score 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multiparametric MRI.Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer.Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer.Magnetic resonance imaging in the early detection of prostate cancer and review of the literature on magnetic resonance imaging-stratified clinical pathways.Current trends in patient enrollment for robotic-assisted laparoscopic prostatectomy in Belgium.The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7-10 prostate cancer in a repeat biopsy setting.Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease.Prostate cancer screening in Europe and Asia.MR-based prognostic nomogram for prostate cancer after radical prostatectomy.Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection.Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
P2860
Q28075610-E9CE7DD6-B820-4F1C-BA99-73E6D4226F1DQ33783620-EE57C08C-3837-4E13-93BD-F6F3A69A22FEQ36265470-2F14E564-8406-4E02-A743-BEF029964441Q36364446-217740C3-FCA5-4304-8CC8-E27E41F289C2Q38815543-1409C0C5-FB33-4598-B011-2BB46C62B642Q38924660-00FE2BA5-B178-47BB-ACBA-4633758EA6CCQ39106378-C3D6526E-498B-4182-B5FF-C1C4A0AD8EADQ40212899-0BCA6F52-9735-478A-BC7E-052601E59FF0Q41474330-8370FE34-27A1-4B4A-AE59-044771A7529CQ47393127-FF62B12E-094C-4024-8D13-0F4541539FC7Q47573527-4A20CFEB-CB0E-48DC-AF60-DA6FE1FF7BE2Q47811496-DED7BC91-DA69-4C85-A0B2-163D24C5B989Q47949163-80AC2723-9DBE-4DF4-B954-D17158BFACF3Q48029204-64EA1367-DC29-40B2-A34B-50EE22EFB9DBQ51595856-B7A9F02E-CA40-4598-8CB0-0CB20F83FA1CQ51733070-4D10C136-8C13-45EE-B01E-46EB67A3145CQ51771288-E1496CAD-2F74-44C4-98AB-21A4B25DED13Q51799851-7D07C721-81B3-404C-A7E6-C375317EABDCQ52665654-443DE8B1-E8B1-4A51-B522-D4A3C975CC03Q54974754-C02254CD-3652-406E-B18C-AF5B52861B5EQ55421492-286D815E-246A-43B0-AFDF-F9F248232721
P2860
Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Combination of prostate imagin ...... rostate biopsy naïve patients.
@ast
Combination of prostate imagin ...... rostate biopsy naïve patients.
@en
type
label
Combination of prostate imagin ...... rostate biopsy naïve patients.
@ast
Combination of prostate imagin ...... rostate biopsy naïve patients.
@en
prefLabel
Combination of prostate imagin ...... rostate biopsy naïve patients.
@ast
Combination of prostate imagin ...... rostate biopsy naïve patients.
@en
P2093
P2860
P356
P1433
P1476
Combination of prostate imagin ...... rostate biopsy naïve patients.
@en
P2093
Kimitoshi Saito
Masaru Hirai
Satoshi Washino
Tomoaki Miyagawa
Tomohisa Okochi
Tsuzumi Konishi
Yutaka Kobayashi
P2860
P304
P356
10.1111/BJU.13465
P577
2016-03-02T00:00:00Z